Translational regulation of the synthesis of dihydrofolate reductase.
Ercikan
E
E
Program of Molecular Pharmacology and Therapeutics, Sloan-Kettering Institute for Cancer Research, New York, NY 10021.
Banerjee
D
D
Waltham
M
M
Schnieders
B
B
Scotto
K W
KW
Bertino
J R
JR
D000818:Animals; D001483:Base Sequence; D001943:Breast Neoplasms; D016466:CHO Cells; D002460:Cell Line; D002474:Cell-Free System; D006224:Cricetinae; D017931:DNA Primers; D018076:DNA, Complementary / Q000378:metabolism; D004273:DNA, Neoplasm / Q000302:isolation & purification / Q000378:metabolism; D005260:Female; D005493:Folic Acid Antagonists; D015971:Gene Expression Regulation, Enzymologic; D006801:Humans; D008727:Methotrexate / Q000494:pharmacology; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction; D014176:Protein Biosynthesis; D012333:RNA, Messenger / Q000378:metabolism; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000378:metabolism; D012156:Reticulocytes / Q000378:metabolism; D013762:Tetrahydrofolate Dehydrogenase / Q000096:biosynthesis* / Q000378:metabolism; D014158:Transcription, Genetic; D014162:Transfection; D014407:Tumor Cells, Cultured
D017931:DNA Primers; D018076:DNA, Complementary; D004273:DNA, Neoplasm; D005493:Folic Acid Antagonists; D012333:RNA, Messenger; D011994:Recombinant Proteins; D013762:Tetrahydrofolate Dehydrogenase; D008727:Methotrexate